KATHMANDU, August 23: An additional 559,000 doses of AstraZeneca vaccines donated by Japan arrived in Nepal on Monday.

KATHMANDU, August 14: The Ministry of Health and Population (MoHP) has said the inoculation of the second dose of COVID-19 vaccine after a long interval of the first dose would still be effective.

KATHMANDU, August 9: The government is administering the second dose of Covishield vaccine to the elderly from today.

LONDON, June 18 : AstraZeneca on Friday said the European Union had lost a legal case against the pharmaceutical firm over the supply of COVID-19 vaccines as a court in Brussels rejected an EU request for more deliveries by the end of June.

KATHMANDU, June 7: The government has decided to provide the AstraZeneca COVID-19 vaccine as an alternative to the booster dose of the Covishield vaccine.

KATHMANDU, May 24: A British study has concluded the Astrazeneca vaccine to be effective against the new variant of the novel coronavirus (COVID-19) disease. According to the BBC, the vaccines developed by American companies like Pfizer, Oxford, and AstraZeneca are found to be effective against the contagious variant B.1.617.2 found in India.

EUROPE, April 27: The European Commission said on Monday it had launched legal action against AstraZeneca (AZN.L) for not respecting its contract for the supply of COVID-19 vaccines and for not having a "reliable" plan to ensure timely deliveries.

NEW DELHI, March 28: A World Health Organization (WHO)-backed programme to supply coronavirus vaccines to poorer countries expects that the Serum Institute of India (SII) will resume full deliveries of the AstraZeneca shot to it in May, UNICEF said on Saturday.

WASHINGTON, Mar 23: AstraZeneca reported Monday that its COVID-19 vaccine provided strong protection among adults of all ages in a long-anticipated U.S. study, a finding that could help rebuild public confidence in the shot around the world and move it a step closer to clearance in the U.S.

TAIPEI, March 22: Health care workers received the first shots in Taiwan’s COVID-19 vaccination drive Monday, beginning a campaign that won’t use supplies from China amid uneven distribution of the vaccines globally.

NEW YORK, Mar 15: AstraZeneca Plc said on Sunday a review of safety data of people vaccinated with its COVID-19 vaccine has shown no evidence of an increased risk of blood clots.

GENEVA, Feb 16: The World Health Organization (WHO) on Monday listed AstraZeneca and Oxford University’s COVID-19 vaccine for emergency use, widening access to the relatively inexpensive shot in the developing world.

LONDON, Jan 4: Britain began vaccinating its population with Oxford University and AstraZeneca’s COVID-19 shot on Monday in a world first, racing to give protection to the elderly and vulnerable as a new surge of cases threatened to overwhelm hospitals.

NEW DELHI, Jan 2: India has approved the COVID-19 vaccine developed by AstraZeneca and Oxford University, paving the way for a huge immunisation campaign in the world’s second most populous country.

ZURICH, Dec 31: Britain on Wednesday became the first country to approve AstraZeneca and Oxford University’s home-grown UK COVID-19 vaccine, adding an easy-to-manage shot to the arsenal of a nation desperate for pandemic relief.

LONDON, Dec 28: The head of drugmaker AstraZeneca, which is developing a coronavirus vaccine widely expected to be approved by U.K. authorities this week, said Sunday that researchers believe the shot will be effective against a new variant of the virus driving a rapid surge in infections in Britain.

LONDON, Dec 12: Britain’s AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.

NEW DELHI/BENGALURU, Dec 7: India is accelerating its review of coronavirus vaccines developed by Pfizer Inc and AstraZeneca for emergency use, a senior government official said on Monday, as the world’s second-most affected country struggles to contain the outbreak.

LONDON, Nov 23:  AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.

LONDON, Oct 26: Early results from tests for a coronavirus vaccine being developed by the University of Oxford, in collaboration with AstraZeneca Plc, show it produces a robust immune response in elderly people, the group at highest risk, the Financial Times reported on Monday.

LONDON, Sept 13: AstraZeneca AZN.L has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after getting the green light from safety watchdogs, the company said on Saturday.

LONDON, Sept 9:  AstraZeneca Plc AZN.L said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

LONDON, July 20: AstraZeneca’s experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data showed on Monday. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain’s University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal.